Dear Members,
The Working Group on Atherosclerosis and Vascular Biology gathers international experts from both basic and clinical science raising awareness of cutting-edge vascular biology research and its application to improve the patient outcome. Our objective is to discuss in depth novel findings and key concepts, from a translational point of view, and share our work with other ESC Working Groups and associations to strengthen the outcomes. We disseminate our messages to cardiologists and researchers through publication of Position Papers and organisation of symposia/sessions at both ESC and external congresses as well as educational activities.
As chairperson of this Working Group, I am glad to share the leadership with outstanding scientists, Magnus Bäck (past-chairperson) and Esther Lutgens (vice-chairperson). I am also delighted to welcome the new enthusiastic nucleus members:
Claudia Goettsch, Aachen, Germany
Isabel Goncalves, Stockholm, Sweden
Claudia Monaco, Oxford, United Kingdom
Konstantinos Stellos, Newcastle, United Kingdom
Kim Van Der Heiden, Rotterdam, Netherlands
I am looking forward to exciting knowledge sharing and a fruitful collaboration with all Working Group members.
I would like to take this opportunity to congratulate two young researchers who received Young Investigator Awards, one in the field of Atherosclerosis and the other one in the field of Vascular Biology: Elisa Avolio (Bristol, UK) for her study “Human adventitial pericytes secrete bioactive factors exerting distinct biological effects on cardiac cells: hints for cardiac repair” and Sebastian Koenig (Freiburg, Germany) for his study “Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice”.
On behalf of the Working Group nucleus,
Marie-Luce Piallat, Chairperson 2020-2022
Our mission: To reduce the burden of cardiovascular disease.